Predictive Oncology extends LOI with Renovaro to March 31, receives $500K initial investment

Axe Compute Inc.

LOI amended: Renovaro's obligation to acquire certain POAI shares eliminated; termination date extended to March 31, 2025.
Renovaro paid $500,000 for 467,290 shares; additional $964,389 for 901,298 shares conditioned on definitive agreement.
Both companies expect to sign definitive merger agreement within next few weeks, per March 3 press release.
First tranche of financing received to initiate integration of AI/ML platforms and lab capabilities in US and Europe.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.